BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29050320)

  • 1. Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells.
    Gatla HR; Zou Y; Uddin MM; Vancurova I
    Oncotarget; 2017 Sep; 8(41):70798-70810. PubMed ID: 29050320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells.
    Gatla HR; Zou Y; Uddin MM; Singha B; Bu P; Vancura A; Vancurova I
    J Biol Chem; 2017 Mar; 292(12):5043-5054. PubMed ID: 28167529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
    Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
    Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
    Kim SN; Kim NH; Lee W; Seo DW; Kim YK
    Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter.
    Mehra-Chaudhary R; Matsui H; Raghow R
    Biochem J; 2001 Jan; 353(Pt 1):13-22. PubMed ID: 11115394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP; Westerheide SD; Baldwin AS
    Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes.
    Wang JH; Shih KS; Wu YW; Wang AW; Yang CR
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1987-96. PubMed ID: 24107356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of HDAC and HAT genes in atrophying skeletal muscle.
    Beharry AW; Judge AR
    Muscle Nerve; 2015 Dec; 52(6):1098-101. PubMed ID: 26372908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity.
    Ray S; Sherman CT; Lu M; Brasier AR
    Mol Endocrinol; 2002 Apr; 16(4):824-36. PubMed ID: 11923478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells.
    Chen Y; Shu W; Chen W; Wu Q; Liu H; Cui G
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):427-33. PubMed ID: 17927689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
    Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
    Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation.
    Somanna NK; Valente AJ; Krenz M; McDonald KS; Higashi Y; Noda M; Chandrasekar B
    Hypertens Res; 2016 Oct; 39(10):709-716. PubMed ID: 27278287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8 Induces Proliferation of Ovarian Cancer Cells in 3D Spheroids.
    Uddin MM; Gaire B; Vancurova I
    Methods Mol Biol; 2020; 2108():117-124. PubMed ID: 31939175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.